mm 3 12 2017 - constant contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… ·...

9
Routing List •Owner •Front Manager •Pharmacy Manager •Other MONEY MAKER Volume 20, Issue 10 • March 12, 2017 Please note: Money Maker prices are listed as Net Invoice Price (NIP) and reflect all invoice discounts. All prices are valid through March 22, 2017 unless otherwise noted or until stock has been exhausted. Phone .......... (919) 596-2151 Toll-Free ...... (800) 800-8551 Fax............... (919) 596-1453 CII Fax ......... (919) 598-4994 Customer Service ....................... (800) 804-0153 After Hours Tech Support ........... (866) 255-2940 Automated Inventory System..... (800) 504-7473 Electronic Order Entry ................ (800) 800-8554 Recalls 1. Zydus Pharmaceuticals has issued a voluntary recall, to the retail level, for two lots of Atenolol tablets, 50 mg. Zydus has decided to initiate voluntary recall based on a single product complaint where the complainant found one tablet of Paroxetine 20mg tablets in repackaged bottle of Atenolol Tablets USP, 50mg, Lot Z600725. For more information see page 10. Announcements 1. Generic Pristiq Now Available Mutual Drug is now stocking generic Pristiq (Desvenlafaxine ER). e 25 MG is being marketed by Teva/ Actavis, while the 50 MG and 100 MG is being marketed by Breckenridge Pharmaceuticals. Be sure to add to your next order today! Item # Description NDC AWP* 258-178 DESVENLAFAXINE ER TAB 25 MG 30 00591-4060-30 $26.70 258-038 DESVENLAFAXINE ER TAB 50 MG 30 51991-0311-33 $28.19 258-368 DESVENLAFAXINE ER TAB 50 MG 90 51991-0311-90 $83.57 258-061 DESVENLAFAXINE ER TAB 100 MG 30 51991-0312-33 $28.19 258-350 DESVENLAFAXINE ER TAB 100 MG 90 51991-0312-90 $83.57 *NIP as of 3/9/2017 and subject to change without prior notice 2. Generic Oxycontin Coming Soon Impax Pharmaceuticals expects to receive their allocations of generic Oxycontin (Oxycodone ER) in March. All strengths are expected to be available in limited quantities. Please note that a 222 form is required for all CII items, and all orders will be subject to SOMS restrictions. More information will be communicated as soon as it becomes available. 3. Exclusivity Reminders Exclusivity periods are oſten granted to new ANDA applicants who are awarded first-to-file status. ese periods afford usually a single generic company a finite period of time in which they can market their generic product. At the end of an exclusivity period, other competition may launch, which my drastically impact market pricing. It is important that you monitor your inventory closely during these periods so as to avoid getting caught with expensive product when cheaper product becomes available. As per Mutual Drug policy, shelf stocks are not available to the retail level. e following products have expected exclusivity periods that expire on or near the dates below: Item # Description NDC Potential Loss of Exclusivity** 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10 MCG 18 65162-0226-23 April 15, 2017 234-013 OLMESARTAN MEDOXOMIL TAB 5 MG 30 00378-7012-93 April 24, 2017 234-021 OLMESARTAN MEDOXOMIL TAB 20 MG 30 00378-7112-93 April 24, 2017 234-039 OLMESARTAN MEDOXOMIL TAB 40 MG 30 00378-7124-93 April 24, 2017 234-112 OLMESARTAN/HCTZ TAB 20/12.5 MG 30 00378-1413-93 April 24, 2017 234-120 OLMESARTAN/HCTZ TAB 40/12.5 MG 30 00378-1422-93 April 24, 2017 234-138 OLMESARTAN/HCTZ TAB 40/25 MG 30 00378-1425-93 April 24, 2017 241-398 EZETIMIBE TAB 10 MG 30 49884-0228-11 June 10, 2017 241-414 EZETIMIBE TAB 10 MG 90 49884-0228-09 June 10, 2017 ** Dates are estimates only. Mutual Drug will continue to work with vendors to determine exact launch plans and dates of other manufacturers.

Upload: others

Post on 24-Sep-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

Routing List•Owner •Front Manager•Pharmacy Manager•Other

MONEY MAKERVolume 20, Issue 10 • March 12, 2017

Please note: Money Maker prices are listed as NetInvoice Price (NIP) and reflect all invoice discounts.All prices are valid through March 22, 2017 unless otherwise noted or until stock has been exhausted.

Phone .......... (919) 596-2151Toll-Free ...... (800) 800-8551Fax ............... (919) 596-1453CII Fax ......... (919) 598-4994

Customer Service ....................... (800) 804-0153After Hours Tech Support ...........(866) 255-2940Automated Inventory System ..... (800) 504-7473Electronic Order Entry ................(800) 800-8554

Recalls 1. Zydus Pharmaceuticals has issued a voluntary recall, to the retail level, for two lots of Atenolol tablets, 50 mg. Zydus has decided to initiate voluntary recall based on a single product complaint where the complainant found one tablet of Paroxetine 20mg tablets in repackaged bottle of Atenolol Tablets USP, 50mg, Lot Z600725. For more information see page 10.

Announcements 1. Generic Pristiq Now AvailableMutual Drug is now stocking generic Pristiq (Desvenlafaxine ER). The 25 MG is being marketed by Teva/ Actavis, while the 50 MG and 100 MG is being marketed by Breckenridge Pharmaceuticals. Be sure to add to your next order today!Item # Description NDC AWP* 258-178 DESVENLAFAXINE ER TAB 25 MG 30 00591-4060-30 $26.70 258-038 DESVENLAFAXINE ER TAB 50 MG 30 51991-0311-33 $28.19 258-368 DESVENLAFAXINE ER TAB 50 MG 90 51991-0311-90 $83.57 258-061 DESVENLAFAXINE ER TAB 100 MG 30 51991-0312-33 $28.19 258-350 DESVENLAFAXINE ER TAB 100 MG 90 51991-0312-90 $83.57

*NIP as of 3/9/2017 and subject to change without prior notice

2. Generic Oxycontin Coming SoonImpax Pharmaceuticals expects to receive their allocations of generic Oxycontin (Oxycodone ER) in March. All strengths are expectedto be available in limited quantities. Please note that a 222 form is required for all CII items, and all orders will be subject to SOMSrestrictions. More information will be communicated as soon as it becomes available.

3. Exclusivity RemindersExclusivity periods are often granted to new ANDA applicants who are awarded first-to-file status. These periods afford usually a singlegeneric company a finite period of time in which they can market their generic product. At the end of an exclusivity period, othercompetition may launch, which my drastically impact market pricing. It is important that you monitor your inventory closely duringthese periods so as to avoid getting caught with expensive product when cheaper product becomes available. As per Mutual Drug policy,shelf stocks are not available to the retail level. The following products have expected exclusivity periods that expire on or near the dates below:Item # Description NDC Potential Loss of Exclusivity**234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017234-989 YUVAFEM TAB 10 MCG 18 65162-0226-23 April 15, 2017234-013 OLMESARTAN MEDOXOMIL TAB 5 MG 30 00378-7012-93 April 24, 2017234-021 OLMESARTAN MEDOXOMIL TAB 20 MG 30 00378-7112-93 April 24, 2017234-039 OLMESARTAN MEDOXOMIL TAB 40 MG 30 00378-7124-93 April 24, 2017234-112 OLMESARTAN/HCTZ TAB 20/12.5 MG 30 00378-1413-93 April 24, 2017234-120 OLMESARTAN/HCTZ TAB 40/12.5 MG 30 00378-1422-93 April 24, 2017234-138 OLMESARTAN/HCTZ TAB 40/25 MG 30 00378-1425-93 April 24, 2017241-398 EZETIMIBE TAB 10 MG 30 49884-0228-11 June 10, 2017241-414 EZETIMIBE TAB 10 MG 90 49884-0228-09 June 10, 2017

** Dates are estimates only. Mutual Drug will continue to work with vendors to determine exact launch plans and dates of other manufacturers.

Page 2: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

2

Announcements (continued)

4. New Generics Coming Soon (Updated 3/9/2017)Mutual Drug is anticipating the launches of several generics inthe near future including the following:• Coreg CR (Carvedilol CR): To be determined.• Minastrin FE (Ethinyl Estradiol; Norethindrone Acetate): March 15, 2017 Expected• ProAir HFA (Albuterol Sulfate): 2017 Expected• Relpax (Eletriptan HBR): March Expected• Suboxone Film Strips (Buprenorphine HCL/ Naloxone): To be determined• Tracleer (Bosentan): 1Q 2017• Vytorin (Ezetimibe; Simvastatin): March 25, 2017 ExpectedAll dates are subject to change without prior notice. Mutual Drug will provide more information as it becomes available.

RemindersReturning Defective Durable Medical EquipmentPlease contact Jennifer Fulford or Chelsea Oakley before return-ing defective DME products to Mutual Drug. Whether the item is new and defective, or it has been used at the consumer level and needs a new part, please provide as much detail as possible.

Coupon Redemption CenterFor personalized service to solve all your coupon handling prob-lems, contact Couponics, Inc. Contact Stan Grossman with any questions at 800-666-6534 or email [email protected].

Returns NoticeWhen placing items in returning totes, please be sure to provide contact information. If items are returned without information we cannot contact the store and/or give credit. For returning items that require refrigeration, please follow the guidelines provided on www.mdmembers.com. If these items are returned in the totes, they will need to be placed in the morgue, as they cannot return to inventory. Please ensure all totes are checked before returning them to Mutual Drug.

Bulletin Board1. Pharmacy Clearing HousePharmacy Clearing House is an online marketplace for buyingand selling pre-owned pharmacy equipment. A broad selection of equipment is available including store fixtures and manufacturer refurbished robots at significantly lower prices than new. Quality equipment with a substantial savings. Sellers only pay if a transac-tion is completed through Pharmacy Clearing House. Check the website for weekly deals and specials.

www.pharmacyclearinghouse.com • 925-895-1506

ACP’s Legislative Updates Updated 3/6/2017

Governor Roy Cooper released his proposed budget for the 2017-2018 fiscal year, which focuses on “identifying common ground solutions.” State Budget Director Charles Perusse presented the highlights to the Joint Appropriations Committee meeting on Thursday morning, March 2. It does not include any new tax increases, but would reinstate the film and entertainment tax incentive rebate and the NC Child and Dependent Care Tax Credit. The current-year surplus is estimated to be $552.6 million. Below are highlights from the recommended budget:• Making North Carolina a top-10 educated state by 2025• Growing middle class paychecks statewide• Building healthier and safer communities• Protecting and growing natural and cultural resources• Exercising fiscal responsibilityEmergency Management: Allocates $100 million to Disaster Reserve and additional $300 million into the Savings Reserve.State Employees and Teachers: Teachers would receive an additional $271 million, which is a 5% average salary increase each year. It would bring all state employees to at least the middle of their position’s salary range.Health and Human Services: Fully funds Medicaid and a couple of Medicaid expansions services. It would also invest in early learning including eliminating the waitlist for NC Pre-K. It includes a $12 million opioid package for mental health services. Senate Bill 175 (S. 175) “Strengthen Opioid Misuse Prevention” (STOP): In an effort to curb opioid abuse in North Carolina, S. 175 was introduced on Thursday, March 2. Representative Craig Horn (R-Union), Representative Greg Murphy (R-Pitt), Representative Ted Davis (R-New Hanover), Representative Chris Malone (R-Wake), Senator Jim Davis (R-Macon), Senator Tom McInnis (R-Richmond), Senator Bill Rabon (R-Brunswick), and Attorney General Josh Stein held a press conference on Thursday to unveil the proposal. ACP has been meeting throughout the session with the sponsors to lend input as this legislation was being discussed. Thursday was the first opportunity to view the final draft legislation and ACP will continue to work with bill sponsors to address issues concerning pharmacy. This is a complicated bill with the sponsors trying to cover a wide rangeof control medication problems. However, as a pharmacist, you see several practical problems exist with the bill as written. In Washington, there seems to be a draft ACA replacement bill on the move. The bill appears to dismantle ACA subsidies and scrap Medicaid expansion. The document is more detailed than the outline that House leaders circulated before their recess. However, several lawmakers are still in disagreement about several key issues, including Medicaid and the size and form of subsidies. The legislation will also be shaped by findings from the Congressional Budget Office (CBO) about the costs and federal deficit implications. Another sign of trouble with this draft is that the House Energy and Commerce and Ways and Means committees haven’t scheduled any markups of the legislation, despite Republicans leaders’ statements that they would release more details right after the congressional recess. President Trump has said he expects a plan to emerge in early to mid-March.

Page 3: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

3

CAPS Back OrderACTAVIS054-254 LEVETIRACETAM ER TAB 750 MG 60 WEEK OF 03/20/2017 EXPECTED755-496 MINOCYCLINE HCL CAP 50 MG 100 WEEK OF 05/01/2017 EXPECTED

AKORN090-076 MYORISAN (ISOTRETINOIN) CAP 40 MG 30 EXPECTED MID MARCH 2017

AMNEAL701-045 IBUPROFEN TAB 600 MG 500 WEEK OF 03/13/2017 EXPECTED

APOTEX056-887 ATORVASTATIN CALCIUM TAB 20 MG 1000 WEEK OF 03/13/2017 EXPECTED

CITRON156-224 PENICILLIN V (ROUND) TAB 250 MG 100 WEEK OF 03/13/2017 EXPECTED

DR. REDDY’S109-819 RIVASTIGMINE TARTRATE CAP 1.5 MG 60776-229 SUMATRIPTAN TAB 50 MG 9 WEEK OF 03/13/2017 EXPECTED109-827 RIVASTIGMINE TARTRATE CAP 3 MG 60 EXPECTED MID MARCH 2017

GLENMARK849-356 ROPINIROLE HCL TAB 3 MG 100149-518 ZONISAMIDE CAP 50 MG 100836-676 FELODIPINE ER TAB 10 MG 100 BROWN WEEK OF 03/27/2017 EXPECTED

IMPAX172-189 BUDESONIDE INHAL SUSP 0.25MG/2ML 30172-171 BUDESONIDE INHAL SUSP 0.5MG/2ML 30 EXPECTED MID MARCH 2017

MAJOR166-504 APRODINE TAB 60/2.5 MG 24 EXPECTED MID MARCH 2017

MYLAN854-034 CARBAMAZEPINE ER CAP 200 MG 120854-042 CARBAMAZEPINE ER CAP 300 MG 120 WEEK OF 05/15/2017 EXPECTED

ORCHID123-083 ESZOPICLONE TAB 2 MG 100 EXPECTED MARCH 2017

PAR (QUALITEST) 200-915 GLIPIZIDE XL TAB 5 MG 500732-131 PROMETHAZINE COD SYR 10/6.25MG/5ML 16 OZ WEEK OF 03/13/2017 EXPECTED151-308 AMLODIPINE BES/VALSARTAN TAB 10/160 MG 30231-407 DILTIAZEM CD ER CAP 120 MG 500 WEEK OF 03/20/2017 EXPECTED

PERRIGO361-469 CLOTRIMAZOLE CREAM 1% 15 GM (OTC) 849-737 FEXOFENADINE TAB 180 MG 100 (OTC) 198-911 IMIQUIMOD CREAM 5% 24 WEEK OF 03/13/2017 EXPECTED169-748 OLOPATADINE NASAL SPRAY 0.6% 30.5 GM EXPECTED APRIL 2017

SANDOZ119-941 ZINC OXIDE OINT TUBE 20% 2 OZ WEEK OF 03/20/2017 EXPECTED

TEVA158-535 AMLOD/VALSARTAN/HCTZ TAB 5/160/12.5 MG 30103-861 FAMOTIDINE TAB 20 MG 1000 WEEK OF 03/13/2017 EXPECTED608-521 FAMOTIDINE TAB 20 MG 1000 WEEK OF 03/27/2017 EXPECTED

VALEANT059-881 NEO/POLY B HC OTIC SOL 10 ML109-926 SULFACETAMIDE SOD OPHTH SOL 10% 15 ML WEEK OF 03/13/2017 EXPECTED

WOCKHARDT230-276 CLOBETASOL TOP SOL USP 0.05% 25 ML EXPECTED EARLY MARCH 2017

ZYDUS797-290 SIMVASTATIN TAB 80 MG 90 WEEK OF 03/13/2017 EXPECTED

Page 4: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

4

CAPS DecreaseACTAVISITEM ID DESCRIPTION NDC NIP AWP201-913 NYSTATIN TRIAMCINOLONE ACT CREAM 15 GM 00472-0150-15 $43.39 $111.94201-962 NYSTATIN TRIAMCINOLONE ACT CREAM 30 GM 00472-0150-30 $69.45 $159.51202-036 NYSTATIN TRIAMCINOLONE ACT CREAM 60 GM 00472-0150-60 $111.10 $227.30202-069 NYSTATIN TRIAMCINOLONE ACT OINT 15 GM 00472-0155-15 $43.39 $111.94202-085 NYSTATIN TRIAMCINOLONE ACT OINT 30 GM 00472-0155-30 $69.45 $159.52202-101 NYSTATIN TRIAMCINOLONE ACT OINT 60 GM 00472-0155-60 $111.10 $227.30

ANIITEM ID DESCRIPTION NDC NIP AWP226-118 HYDROCORTISONE CREAM 2.5 % 30 GM 62559-0431-30 $24.88 $83.16

APOTEXITEM ID DESCRIPTION NDC NIP AWP231-696 OMEGA 3 ACID ETHYL ESTERS CAP 1 GM 120 60505-3170-07 $40.97 $248.14

AUROBINDOITEM ID DESCRIPTION NDC NIP AWP191-585 ENTECAVIR TAB 0.5 MG 30 65862-0841-30 $439.21 $1,333.05191-593 ENTECAVIR TAB 1 MG 30 65862-0842-30 $439.21 $1,333.05

MALLINCRODTITEM ID DESCRIPTION NDC NIP AWP134-460 HYDROMORPHONE ER TAB 16 MG 100 00406-3316-01 $1,593.04 $2,707.96394-726 MORPHINE SULFATE ER TAB 100 MG 100 00406-8390-01 $88.90 $919.95394-668 MORPHINE SULFATE ER TAB 15 MG 100 00406-8315-01 $15.75 $167.57394-684 MORPHINE SULFATE ER TAB 30 MG 100 00406-8330-01 $29.97 $317.19394-700 MORPHINE SULFATE ER TAB 60 MG 100 00406-8380-01 $52.06 $621.33

PRASCOITEM ID DESCRIPTION NDC NIP AWP161-570 COLCHICINE TAB 0.6 MG 100 (AG) 66993-0165-02 $495.40 $673.63

TRISITEM ID DESCRIPTION NDC NIP AWP161-141 HYDROCODONE BIT/APAP TAB 10/325 MG 1000 27808-0037-03 $87.33 $908.60161-125 HYDROCODONE BIT/APAP TAB 5/325 MG 1000 27808-0035-03 $87.33 $656.90161-133 HYDROCODONE BIT/APAP TAB 7.5/325 MG 1000 27808-0036-03 $87.33 $731.70

CAPS IncreaseRISINGITEM ID DESCRIPTION NDC NIP AWP729-590 DIPYRIDAMOLE TAB 25 MG 100 64980-0133-01 $40.58 $106.05729-616 DIPYRIDAMOLE TAB 50 MG 100 64980-0134-01 $65.36 $170.82729-640 DIPYRIDAMOLE TAB 75 MG 100 64980-0135-01 $87.46 $228.56

Page 5: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

5

CAPS NewACTAVISITEM ID DESCRIPTION NDC NIP AWP258-178 DESVENLAFAXINE ER TAB 25 MG 30 00591-4060-30 $26.70 $344.20

COMPARE TO: PRISTIQ ER

AKORNITEM ID DESCRIPTION NDC NIP AWP258-004 BRIMONIDINE TARTRATE OPHTH SOL 0.2% 10 ML 17478-0715-11 $4.75 $65.24

COMPARE TO: ALPHAGAN REPLACES: 160-135

BRECKENRIDGEITEM ID DESCRIPTION NDC NIP AWP 258-061 DESVENLAFAXINE ER TAB 100 MG 30 51991-0312-33 $28.19 $344.04258-350 DESVENLAFAXINE ER TAB 100 MG 90 51991-0312-90 $83.57 $1,032.12258-038 DESVENLAFAXINE ER TAB 50 MG 30 51991-0311-33 $28.19 $344.04258-368 DESVENLAFAXINE ER TAB 50 MG 90 51991-0311-90 $83.57 $1,032.12

COMPARE TO: PRISTIQ ER

DR. REDDY'SITEM ID DESCRIPTION NDC NIP AWP 258-152 LAMOTRIGINE ODT TAB 25 MG 30 43598-0550-30 $189.00 $268.36

COMPARE TO: LAMICTIL

GREENSTONEITEM ID DESCRIPTION NDC NIP AWP 255-547 TRIAZOLAM TAB 0.25 MG 100 59762-3718-90 $122.06 $366.70

COMPARE TO: HALCION, REPLACES: 623-223

MAYNEITEM ID DESCRIPTION NDC NIP AWP 257-345 CLONIDINE TRANS SYS 0.3 MG/DAY (1X4) 51862-0455-04 $113.01 $309.79

COMPARE TO: CATAPRES TTS, REPLACES: 855-460

PARITEM ID DESCRIPTION NDC NIP AWP 249-508 DILTIAZEM CD ER CAP 120 MG 30 10370-0829-11 $9.93 $36.70

COMPARE TO: CARDIZEM CD, REPLACES: 048-769

SOLCOITEM ID DESCRIPTION NDC NIP AWP 256-438 IRBESARTAN TAB 150 MG 30 43547-0375-03 $4.89 $92.15

COMPARE TO: AVAPRO, REPLACES: 043-646248-401 IRBESARTAN TAB 300 MG 30 43547-0279-03 $7.90 $110.80

COMPARE TO: AVAPRO, REPLACES: 043-679248-369 IRBESARTAN TAB 75 MG 30 43547-0277-03 $3.98 $87.60

COMPARE TO: AVAPRO, REPLACES: 043-638248-500 LEVETIRACETAM ER TAB 500 MG 60 43547-0345-06 $19.37 $268.00

COMPARE TO: KEPPRA XR, REPLACES: 053-116248-518 LEVETIRACETAM ER TAB 750 MG 60 43547-0346-06 $28.34 $400.00

COMPARE TO: KEPPRA XR, REPLACES: 054-254

Page 6: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

6

Rx Branded NewLEO PHARMAITEM ID DESCRIPTION NDC NIP AWP252-593 PROTOPIC OINT 0.1% 30 GM 50222-0211-30 $246.49 $291.71

SPECIFIC USE: ECZEMA, REPLACES: 202-291

VERNALIS THERAPEUTICSITEM ID DESCRIPTION NDC NIP AWP253-294 MOXATAG TAB 775 MG 10 69442-0030-10 $147.85 $174.97

SPECIFIC USE: ANTIBIOTIC

OTC NewEMERSONITEM ID DESCRIPTION NIP250-852 SALONPAS PAIN RELIEVING PATCH LG 6 $24.78

REPLACES: 605-410

HUMCOITEM ID DESCRIPTION NIP257-444 MERTHIOLATE 2 OZ $3.66

REPLACES: 726-661

INTERNATIONAL VITAMINITEM ID DESCRIPTION NIP257-469 TEENAGE MUTANT NINJA TURTLES MULTI GUMMIES 90 $5.80

REPLACES: 094-532

KAOITEM ID DESCRIPTION NIP249-698 BIORE CHARCOAL ACNE SCRUB 4.5 OZ $4.79

PFIZERITEM ID DESCRIPTION NIP257-287 ADVIL LIQUIGEL EZ OPEN 160 $15.07257-253 ADVIL MENSTRUAL PAIN TAB 40 $6.14257-279 ADVIL PM CAPLET EZ OPEN 120 $13.20257-295 ADVIL TABLET EZ OPEN 200 $14.39881-524 CENTRUM SPECIALIST ENERGY TAB 60 $9.61256-974 CHAPSTICK LIP MOIST CARDED 0.15 OZ $1.12256-982 CHAPSTICK MEDICATED CARDED 0.15 OZ $1.33257-014 DIMETAPP CHILD COLD & ALLERGY 4 OZ $4.73257-022 DIMETAPP CHILD COLD & COUGH 4 OZ $4.73257-121 EMERGEN-C IMMUNE + ORANGE CHEWABLES 42 $9.49257-139 EMERGEN-ZZZZ BERRY PM 24 $7.93257-147 PREPARATION H MAX STRENGTH CREAM 1.8 OZ $10.19257-196 PREPARATION H MEDICATED WIPES WOMEN 48 $4.44257-246 PREPARATION H SUPPOSITORIES 12 $6.56257-048 ROBITUSSIN CHILD 12HR COUGH RELIEF GRAPE 3 OZ $7.73257-055 ROBITUSSIN CHILD 12HR COUGH RELIEF ORANGE 3OZ $7.73257-063 ROBITUSSIN MAX STR NIGHTTIME COUGH DM 4 OZ $5.81257-097 ROBITUSSIN SEVERE MS COUGH COLD & FLU 8 OZ $8.84

Page 7: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

7

OTC New (continued)

PHARMAVITEITEM ID DESCRIPTION NIP257-436 FISH OIL SOFTGEL 1200 MG + VIT D 1000IU 90 $10.47257-188 VITAMIN D3 1000 IU CHEW TAB 120 NM $5.72

REPLACES: 896-217

POINT GUARDITEM ID DESCRIPTION NIP251-363 SUPER GLUE 6 CT $0.79251-058 TISSUE PAPER WHITE 20 $0.58

PROCTER & GAMBLEITEM ID DESCRIPTION NIP257-873 ALIGN PROBIOTIC CHEW BANANA STRAWBERRY 24 CT $22.28257-881 OLAY DEEPLY CLEAN MINERAL FACE CLEANSER 5 OZ $4.99257-899 OLAY GENTLE CLEAN FOAMING FACE CLEANSER 5 OZ $3.35257-964 OLAY IN SHOWER FACE SCRUB STRAWBERRY MINT 5OZ $3.60257-956 OLAY LUMINOUS BRIGHT CREAM FACE CLEANSER 5 OZ $5.03257-907 OLAY OIL MINIMIZING FOAMING FACE CLEANSER 5OZ $3.35258-046 SECRET CLINICAL GEL AP/DEO CLEAN 1.6 OZ $5.55258-053 SECRET CLINICAL GEL AP/DEO POWDER 1.6 OZ $5.55258-079 SECRET CLINICAL GEL AP/DEO STRESS RESP 1.6 OZ $5.55258-087 SECRET FRESH INV SOLID AP/DEO BOHOBERRY 2.6OZ $4.38258-095 SECRET FRESH INV SOLID AP/DEO HA/CITRUS 2.6OZ $4.38258-111 SECRET FRESH INV SOLID AP/DEO WATERLILY 2.6OZ $4.38

TEC LABSITEM ID DESCRIPTION NIP257-428 LICE FREE KIT $13.20

OTC SpecialsBAYERITEM ID DESCRIPTION NIP SPECIAL NIP206-110 MIRAFIBER CAPLET 100 $11.35 $8.51206-128 MIRAFIBER ORANGE POWDER 482G $11.35 $8.51206-136 MIRAFIBER ORANGE POWDER SUGAR FREE 482G $11.35 $8.51

25% OFF THROUGH 3/17/2017

Home Health NewAG INDUSTRIESITEM ID DESCRIPTION NIP256-875 FILTER CONCENTRATOR INTAKE EVERFLO $4.77

REPLACES: 822-544

DYNAREXITEM ID DESCRIPTION NIP257-774 TOOTHETTE ORAL SWABSTICKS UNFLAVORED BX/250 $15.05 257-584 TOWELETTE BENZALKONIUM BZK ANTISEPTIC 100 $1.44

Page 8: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

Home Health New (continued)

MEDLINEITEM ID DESCRIPTION NIP258-137 NEBULIZER COMP AEROMIST COMPACT W/DISP NEB $17.92

REPLACES: 227-249

POSEYITEM ID DESCRIPTION NIP833-608 HEEL/ELBOW PROTECTOR LG 1 PR $9.48 822-031 HEEL/ELBOW PROTECTOR MD 1 PR $9.48 817-890 SOCKS NON SKID LF GREEN STD PR #6239 $1.93 817-726 SOCKS NON SKID LF PUR LG PR #6239L $2.67

RESMEDITEM ID DESCRIPTION NIP247-866 CPAP MASK W/HEADGEAR AIRFIT F20 FOR HER SM $114.08

9

Page 9: MM 3 12 2017 - Constant Contactfiles.constantcontact.com/d73bebdc101/b15205e2-e91b-474c-8059-… · 234-971 YUVAFEM TAB 10 MCG 8 65162-0226-21 April 15, 2017 234-989 YUVAFEM TAB 10

10

Retail Level Recall